Sunday, 25 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Hengrui’s Lutetium [177Lu] Oxy-Octreotide Gains Clinical Clearance in China
January 20, 2025
Company
Drug
Changchun BCHT Gains NMPA Approval for Herpes Zoster Vaccine
January 20, 2025
Company
Drug
Jemincare’s Avatrombopag Market Filing Accepted for Review by China’s CDE
January 20, 2025
Company
Drug
Ascletis Receives FDA Approval for Phase IIa Trial of ASC10 in RSV Infection
January 20, 2025
Company
Deals
Daewoong Pharmaceutical Licenses Bersiporocin to CSP for Greater China Development
January 20, 2025
Company
Drug
Sirnaomics Accelerates STP705 Development After Positive Skin Cancer Trial Results
January 20, 2025
Company
Drug
Betta Pharmaceuticals Gains FDA Approval for Clinical Trial of BPI-460372
January 20, 2025
Company
Novartis Q4 Results Show Growth in Innovative Medicines Amid Sandoz Spin-Off Plans
January 20, 2025
1
2
…
17
18
19
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
